share_log

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

HeartCore擴大了與Heart-Tech Health的合作伙伴關係,將人工智能功能引入其醫療技術平台。
Benzinga ·  04/22 08:44

HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division ("AI Division") has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech platform.

總部位於東京的領先企業軟件和諮詢服務公司HeartCore Enterprises, Inc.(納斯達克股票代碼:HTCR)(“HeartCore” 或 “公司”)宣佈,其人工智能(AI)軟件開發部(“人工智能部門”)已與Heart-Tech Health合作,在其醫療技術平台中實施人工智能功能。

Heart-Tech Health offers a suite of SaaS solutions designed to identify women's cardiovascular risks at an early stage. Its proprietary software, Adesso, offers a comprehensive risk assessment and personalized health and wellness programs aimed to enhancing healthcare accessibility for all women. Expanding upon the previous engagement with the Company's subsidiary, Sigmaways, HeartCore's AI Division will now develop the AI data base for specific applications and insights, in addition to implementing natural language learning applications to enhance user experience within the Adesso Heart Score platform.

Heart-Tech Health提供了一套SaaS解決方案,旨在儘早識別女性的心血管風險。其專有軟件Adesso提供全面的風險評估和個性化的健康和保健計劃,旨在提高所有女性獲得醫療保健的機會。在先前與公司子公司Sigmaways的合作基礎上,HeartCore的人工智能部門現在將爲特定應用和見解開發人工智能數據庫,此外還將實施自然語言學習應用程序以增強Adesso Heart Score平台內的用戶體驗。

"Scaling up our partnership with HeartCore is a crucial step in technologically advancing our Adesso platform," said Heart-Tech Health Founder and CEO Dr. Suzanne Steinbaum. "At the heart of Adesso lies a commitment to educating and empowering women about cardiovascular risks early on to combat this epidemic. Our software's workflow has undergone substantial improvement, coupled with invaluable leadership guidance since engaging with Sigmaways and their talented development team last year. By partnering with HeartCore's AI division, we aim to harness the potential capabilities of artificial intelligence to propel our platform's efficiency, reach, and accessibility to continue making impactful strides in women's cardiovascular health awareness and prevention."

Heart-Tech Health創始人兼首席執行官蘇珊娜·斯坦鮑姆博士表示:“擴大與HeartCore的合作伙伴關係是推進Adesso平台技術發展的關鍵一步。”“Adesso的核心是致力於儘早對女性進行心血管風險的教育和賦權,以對抗這種流行病。自去年與Sigmaways及其才華橫溢的開發團隊合作以來,我們的軟件工作流程得到了實質性的改進,並得到了寶貴的領導指導。通過與HeartCore的人工智能部門合作,我們的目標是利用人工智能的潛在能力來推動我們平台的效率、覆蓋範圍和可訪問性,繼續在女性心血管健康意識和預防方面取得有影響力的進步。”

HeartCore CEO Sumitaka Kanno Yamamoto added: "I am pleased to announce our second contract awarded to our newly established AI division. AI innovation pairs seamlessly into our broader suite of software solutions, and this contract serves as a prime example of the cross-selling opportunities with our clients across our software business. Our dedicated team continues to make headway, securing new opportunities in the U.S. markets as we actively execute our global expansion initiatives. We are committed to leveraging the full potential and capabilities of AI to propel companies like Heart-Tech Health to drive business success and foster positive societal impact."

HeartCore首席執行官菅野純隆補充說:“我很高興地宣佈,我們向新成立的人工智能部門授予了第二份合同。人工智能創新與我們更廣泛的軟件解決方案套件無縫結合,該合同是我們在軟件業務中與客戶交叉銷售機會的典型例子。我們的專業團隊繼續取得進展,在我們積極執行全球擴張計劃的同時,確保了美國市場的新機遇。我們致力於充分利用人工智能的潛力和能力,推動像Heart-Tech Health這樣的公司推動業務成功併產生積極的社會影響。”

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論